Clinical trial
HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)
NCT00480805 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00480805 |
|---|---|
| Title | HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED) |
| Official title | HYZAAR Versus Ramipril Diabetic Patients |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus, Hypertension |
| Intervention type | Drug |
| Interventions | MK0954A, losartan potassium (+) hydrochlorothiazide (HYZAAR) / Duration of Treatment : 8 Weeks, Comparator : ramipril /Duration of Treatment : 8 Weeks |
| Enrollment | 312 |
| Start date | Aug 8, 2001 |
| Primary completion | Oct 15, 2002 |
| Completion | Oct 16, 2002 |
| First posted | May 31, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: